Having trouble accessing articles? Reset your cache.

OncoGenex prices $50M follow-on

OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) raised $50 million through the sale

Read the full 105 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE